Calendar Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Delayed Swiss Exchange 07:59:06 2024-04-24 am EDT 5-day change 1st Jan Change
0.119 CHF -12.18% Intraday chart for Addex Therapeutics Ltd -36.36% +158.70%

Chart calendar Addex Therapeutics Ltd

6ef318e8246fbcc142c73c70.dyKlEFgwBpmk6uC3XnbU_UOjjnHyEuDlK6hajyZcvVc.T3XLc2xlbK7mqaztMEbmqjbQ2QeEIrW3R_I91Wc5_iYDTdAiDH5wy-eCqQ~637aacb6ad7d31581e12e09ff3671c4f

Upcoming events on Addex Therapeutics Ltd

2024-05-05 Q1 2024 Earnings Release
2024-05-11 Bio Equity Europe Conference
2024-08-11 Q2 2024 Earnings Release
2024-11-10 Q3 2024 Earnings Release
2025-03-05 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)
2025-08-12 Q2 2025 Earnings Release (Projected)
2025-11-05 Q3 2025 Earnings Release (Projected)

Past events on Addex Therapeutics Ltd

2024-04-23 07:45 am Swiss Biotech Day
2024-04-21 Swiss Biotech Day
2024-04-18 10:00 am Q4 2023 Earnings Call
2024-04-18 01:00 am Q4 2023 Earnings Release
2024-03-19 06:00 am BioEurope Spring Conference
2024-01-11 10:20 am Swiss Equities Baader Conference
2024-01-08 07:30 pm Biotech Showcase
2023-12-19 05:00 am Extraordinary Shareholders Meeting
2023-11-29 10:00 am Q3 2023 Earnings Call
2023-11-29 01:00 am Q3 2023 Earnings Release
2023-11-13 Jefferies London Healthcare Conference
2023-11-05 Bio-Europe Conference
2023-09-13 03:00 pm H.C. Wainwright Global Investment Conference - Pre - Recorded
2023-09-12 SCI RSC Medicinal Chemistry Symposium
2023-08-10 10:00 am Q2 2023 Earnings Call
2023-08-10 01:00 am Q2 2023 Earnings Release
2023-05-31 05:00 am Annual General Meeting
2023-05-13 BioEquity Europe Conference
2023-05-11 10:00 am Q1 2023 Earnings Call
2023-05-11 01:00 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
2,76
3,49
-20.89%
3,88
2,85
36.19%
3,15
3,48
-9.29%
1,45
1,15
25.65%
1,65
1,10
49.73%

0,00

EBITDA
Million CHF
Released
Forecast
Spread
-14,3
-10,8
-32.13%
-11,9
-15,5
23.57%
-15,2
-15,6
2.52%
-20,2
-16,6
-22.04%
0,00
-10,1
-

-7,39

EBIT
Million CHF
Released
Forecast
Spread
-14,6
-11,4
-28.12%
-12,2
-15,7
22.16%
-15,5
-15,6
0.31%
-20,5
-16,9
-21.64%
-10,3
-10,3
0.27%

-7,39

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
-14,8
-11,0
-34.37%
-12,9
-16,2
20.62%
-15,4
-15,4
0.21%
-20,8
-17,0
-22.74%
-10,6
-11,3
6.58%

-6,30

Net income
Million CHF
Released
Forecast
Spread
-14,8
-11,0
-34.37%
-12,9
-40,9
68.56%
-15,4
-15,4
0.21%
-20,8
-17,0
-22.74%
-10,6
-11,3
6.58%

-6,30

EPS
CHF
Released
Forecast
Spread
-0,56
-0,42
-33.33%
-0,48
-0,62
22.58%
-0,45
-0,43
-3.85%
-0,46
-0,42
-10.84%
-0,14
-0,17
17.65%

-0,09

Announcement Date08/04/2011/03/2110/03/2230/03/2318/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CHF
Released
Forecast
Spread
0,40
0,48
-15.77%
0,24
0,47
-48.09%
0,19
0,51
-63.53%
0,42
0,23
84.76%



0,33
0,64
-48.67%
0,15
0,65
-76.43%

0,70


0,70


0,70


0,70

EBIT
Million CHF
Released
Forecast
Spread
-4,28
-4,30
0.67%
-5,76
-4,03
-43%
-7,09
-6,49
-9.28%
-4,17
-4,98
16.24%



-2,65
-2,31
-14.85%
-2,68
-2,55
-5.23%












Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
-4,42
-4,33
-2.24%
-5,82
-4,06
-43.63%
-7,22
-6,52
-10.84%
-4,11
-5,08
19.06%



-2,62
-2,43
-7.74%
-2,86
-2,65
-7.85%












Net income
Million CHF
Released
Forecast
Spread
-4,42
-4,33
-2.24%
-5,82
-4,06
-43.63%
-7,22
-6,52
-10.84%
-4,11
-5,08
19.06%
-2,68


-2,62
-2,43
-7.74%
-2,86
-2,65
-7.85%












EPS
CHF
Released
Forecast
Spread
-0,13
-0,10
-30%
-0,15
-0,08
-87.5%
-0,19
-0,13
-46.15%
-0,09
-0,09
0%
-0,04


-0,03
-0,03
0%
-0,03
-0,03
0%

-0,02


-0,02


-0,02


-0,02

Announcement Date10/03/2205/05/2230/07/2211/11/2210/08/2329/11/2318/04/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADXN Stock
  4. Calendar Addex Therapeutics Ltd